Foundation programme

Peptide Therapy Certificate

10 simple modules for beginners in peptide therapy

A practical beginner-level certificate introducing the fundamentals of peptide therapy. Designed for healthcare professionals and students new to the field who want a clear, structured first step.

Now LiveEnrol now

About this programme

This beginner-level certificate breaks peptide therapy into ten accessible modules. It introduces core concepts, common therapeutic classes, safety considerations and the U.S. regulatory context without assuming prior specialist knowledge. The programme is educational and non-promotional, designed to help newcomers build confidence before progressing to advanced Institute training.

Learning objectives

  • Define what peptides are and explain their basic mechanisms of action.
  • Recognise major classes of therapeutic peptides discussed in clinical and research literature.
  • Describe common routes of administration and their practical implications.
  • Identify key safety, side-effect and contraindication considerations.
  • Apply introductory critical-appraisal skills to peptide literature.
  • Outline the U.S. regulatory framework that governs peptide therapies.

Programme outline

  • What peptides are and how they work
  • Major classes of therapeutic peptides
  • Routes of administration and pharmacokinetics
  • Safety, side-effects and contraindications
  • Reading peptide literature critically
  • The U.S. regulatory landscape (FDA, 503A/503B, state oversight)

Format

Online modular learning with structured assessment.

Audience

Healthcare professionals, students and educated newcomers seeking an accessible introduction to peptide therapy.

Prerequisites

None.

Dates & pricing

This programme is open for enrolment. Fees and admissions criteria are available on the course platform.

This programme is educational in nature and written for a United States audience. It does not promote, market or recommend any drug, biologic, device or dietary supplement, and it does not provide prescribing protocols. The U.S. regulatory status of individual peptides — including approval, investigational status, and eligibility for pharmacy compounding under Sections 503A/503B — is determined by the FDA and may change over time. Clinical decisions remain the responsibility of individual U.S.-licensed practitioners operating within their state scope of practice and applicable federal and state law. See our full regulatory disclaimer.